100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19

N Lobo, NA Brooks, AR Zlotta, JD Cirillo… - Nature Reviews …, 2021 - nature.com
Abstract Bacillus Calmette–Guérin (BCG) is the most widely used vaccine worldwide and
has been used to prevent tuberculosis for a century. BCG also stimulates an anti-tumour …

Risks from deferring treatment for genitourinary cancers: a collaborative review to aid triage and management during the COVID-19 pandemic

CJD Wallis, G Novara, L Marandino, A Bex, AM Kamat… - European urology, 2020 - Elsevier
Context The coronavirus disease 2019 (COVID-19) pandemic is leading to delays in the
treatment of many urologic cancers. Objective To provide a contemporary picture of the risks …

BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)

LE Escobar, A Molina-Cruz, C Barillas-Mury - Proceedings of the National …, 2020 - pnas.org
A series of epidemiological explorations has suggested a negative association between
national bacillus Calmette–Guérin (BCG) vaccination policy and the prevalence and …

Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations

J Sultana, G Mazzaglia, N Luxi… - Expert review of …, 2020 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease (COVID-19), caused by severe acute
respiratory syndrome coronavirus (SARS-CoV-2), has quickly spread around the world …

Could the induction of trained immunity by β-glucan serve as a defense against COVID-19?

A Geller, J Yan - Frontiers in immunology, 2020 - frontiersin.org
As the SARS-CoV-2 virus wreaks havoc on the populations, health care infrastructures and
economies of nations around the world, finding ways to protect health care workers and …

SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways

D Mekonnen, HM Mengist, T ** - Expert Review of Vaccines, 2022 - Taylor & Francis
Introduction Vaccines are the agreed upon weapon against the COVID-19 pandemic. This
review discusses about COVID-19 subunit vaccines adjuvants and their signaling pathways …

Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now)

M Riccò, G Gualerzi, S Ranzieri… - Acta Bio Medica …, 2020 - pmc.ncbi.nlm.nih.gov
Since the beginning of the COVID-19 epidemic, a possible explanation for the high
heterogeneity of infection/mortality rates across involved countries was hinted in the …

A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19

S Singh, NA Saavedra-Avila, S Tiwari… - Frontiers in …, 2022 - frontiersin.org
Bacillus Calmette-Guerin (BCG) has been used as a vaccine against tuberculosis since
1921 and remains the only currently approved vaccine for this infection. The recent …

Review of registered clinical trials for the treatment of COVID‐19

F Babaei, M Mirzababaei, M Nassiri‐Asl… - Drug Development …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is a viral disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The disease was first reported in …

How Japan managed to curb the pandemic early on: Lessons learned from the first eight months of COVID-19

UB Sayeed, A Hossain - Journal of global health, 2020 - pmc.ncbi.nlm.nih.gov
Figure 1 shows the incidence pattern of COVID-19 positive cases for the four peer countries
of Japan. The incidence in Japan appears to be small compared to Russia and the United …